STA
XBI icon

Summit Trail Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Summit Trail Advisors’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.57M Hold
9,947
– – 0.02% 761
2026
Q1 		$1.27M Hold
9,947
– – 0.02% 818
2025
Q4 		$1.21M Hold
9,947
– – 0.02% 703
2025
Q3 		$997K Sell
9,947
-61
-0.6% -$5.49K 0.01% 835
2025
Q2 		$830K Sell
10,008
-2,729
-21% -$218K 0.01% 543
2025
Q1 		$1.03M Buy
12,737
+2,941
+30% +$263K 0.03% 154
2024
Q4 		$882K Sell
9,796
-2,752
-22% -$267K 0.03% 148
2024
Q3 		$1.24M Sell
12,548
-2,496
-17% -$245K 0.03% 230
2024
Q2 		$1.39M Sell
15,044
-7,230
-32% -$648K 0.04% 179
2024
Q1 		$2.11M Sell
22,274
-930
-4% -$86.3K 0.06% 127
2023
Q4 		$2.07M Buy
23,204
+5,353
+30% +$398K 0.07% 101
2023
Q3 		$1.3M Sell
17,851
-72,171
-80% -$5.76M 0.05% 131
2023
Q2 		$7.49M Sell
90,022
-120,124
-57% -$10M 0.28% 44
2023
Q1 		$16M Sell
210,146
-54,322
-21% -$4.51M 0.65% 23
2022
Q4 		$22M Buy
264,468
+38,774
+17% +$3.14M 0.98% 15
2022
Q3 		$17.9M Buy
225,694
+157,340
+230% +$13.3M 0.97% 17
2022
Q2 		$5.08M Buy
68,354
+26,815
+65% +$2.01M 0.31% 45
2022
Q1 		$3.73M Sell
41,539
-171,304
-80% -$15.8M 0.3% 50
2021
Q4 		$23.8M Buy
212,843
+168,499
+380% +$20.3M 1.54% 16
2021
Q3 		$5.57M Buy
+44,344
New +$5.71M 0.42% 47

Other funds holding XBI

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Summit Trail Advisors's XBI Position: Q2 2026 in Review

Summit Trail Advisors held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 9,947 shares worth $1.57M. The position accounts for 0.02% of the portfolio, ranked #761.

Summit Trail Advisors first reported a position in XBI in Q3 2021 and has held it in 20 quarters since. The position peaked at $23.8M in Q4 2021. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Summit Trail Advisors held 9,947 shares of State Street SPDR S&P Biotech ETF worth $1.57M as of Q2 2026.
  • Summit Trail Advisors left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
  • State Street SPDR S&P Biotech ETF made up 0.02% of Summit Trail Advisors's portfolio in Q2 2026, its #761 holding.
  • Summit Trail Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q3 2021 and has held it in 20 quarters since.
  • Summit Trail Advisors's State Street SPDR S&P Biotech ETF position peaked at $23.8M in Q4 2021.
  • 933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Summit Trail Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.